Hydrochlorothiazide
- Product NDC
- 72888-491
- Requested package NDC
- 72888-491-01
- 11-digit product format
- 728880491
- Labeler code
- 72888
- Product ID
- 72888-491_5d541861-228e-17b0-e063-6394a90ab61e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Advagen Pharma Ltd
- Application
- ANDA218248
- Marketing category
- ANDA
- Marketing start
- 2026-10-07
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 50 mg/5mL
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218248-001 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 50MG/5ML | SOLUTION / ORAL | RS | 2026-10-07 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A218248-001 | HYDROCHLOROTHIAZIDE | 50MG/5ML | SOLUTION / ORAL | RS | 2026-10-07 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A218248-001 | HYDROCHLOROTHIAZIDE | 50MG/5ML | SOLUTION / ORAL | RS | 2026-10-07 | c2088c7a36db… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Hydrochlorothiazide
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| HYDROCHLOROTHIAZIDE | 50 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0J48LPH2TH | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310813 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f4b10352-a923-4713-9d33-8f3636941b2e | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd | f4b10352-a923-4713-9d33-8f3636941b2e | 2026-10-08 | Warnings, Adverse reactions | 218248 ANDA218248 72888-491-01 72888-491 72888049101 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72888-491-01 | 72888049101 | 1 BOTTLE in 1 CARTON (72888-491-01) / 473 mL in 1 BOTTLE | 1 bottle | 2026-10-07 | No | No | Current |